Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies
Crossref DOI link: https://doi.org/10.1007/s40262-016-0505-1
Published Online: 2017-01-06
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Djebli, Nassim
Martinez, Jean-Marie
Lohan, Laura
Khier, Sonia
Brunet, Aurélie
Hurbin, Fabrice
Fabre, David
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
License valid from 2017-01-06